no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A comparison of the analytical performance of five commercially available assays for neutrophil gelatinase-associated lipocalin using urine
|
Kift, Rebecca L |
|
2013 |
50 |
3 |
p. 236-244 |
article |
2 |
Adjustment of ionized calcium concentration for serum pH is not a valid marker of calcium homeostasis: implications for identifying individuals at risk of calcium metabolic disorders
|
Lam, Virginie |
|
2013 |
50 |
3 |
p. 224-229 |
article |
3 |
A multicentre study comparing two methods for serum free light chain analysis
|
Lock, RJ |
|
2013 |
50 |
3 |
p. 255-261 |
article |
4 |
Analysis of myeloperoxidase activity in wound fluids as a marker of infection
|
Hasmann, A |
|
2013 |
50 |
3 |
p. 245-254 |
article |
5 |
Automation in UK clinical biochemistry
|
Murphy, Michael J |
|
2013 |
50 |
3 |
p. 285-286 |
article |
6 |
A young patient of hereditary renal hypouricaemia presenting with exercise-induced rhabdomyolysis and acute kidney injury
|
Chakraborty, Sutirtha |
|
2013 |
50 |
3 |
p. 271-273 |
article |
7 |
Best practice guidelines on clinical management of acute attacks of porphyria and their complications
|
Stein, Penelope |
|
2013 |
50 |
3 |
p. 217-223 |
article |
8 |
Brain-derived neurotrophic factor: a new face of metabolic disorders
|
Marchelek-Myśliwiec, Małgorzata |
|
2013 |
50 |
3 |
p. 189-190 |
article |
9 |
Decreased levels of serum omentin-1 in patients with obstructive sleep apnoea syndrome
|
Wang, Qiuyan |
|
2013 |
50 |
3 |
p. 230-235 |
article |
10 |
Evaluation of an inductively coupled plasma mass spectrometry method for the analysis of sweat chloride and sodium for use in the diagnosis of cystic fibrosis
|
Pullan, N J |
|
2013 |
50 |
3 |
p. 267-270 |
article |
11 |
Influence of age at diagnosis and duration of diabetes on the positivity of glutamic acid decarboxylase antibody in South-Brazilian type 1 diabetes mellitus
|
Maraschin, Jorge de Faria |
|
2013 |
50 |
3 |
p. 262-266 |
article |
12 |
Insulin-like growth factor 1 bioactivity might reflect different aspects of quality of life than total insulin-like growth factor 1 in growth hormonedeficient patients during growth hormone treatment
|
Bacon, Olivia |
|
2013 |
50 |
3 |
p. 287-287 |
article |
13 |
Isotopically labelled testosterone derivatives as internal standards in liquid chromatography-tandem mass spectrometry
|
Owen, L J |
|
2013 |
50 |
3 |
p. 277-277 |
article |
14 |
Isotopically labelled testosterone derivatives as internal standards in liquid chromatography-tandem mass spectrometry
|
Bui, Hong N |
|
2013 |
50 |
3 |
p. 275-276 |
article |
15 |
It is time to start ordering ionized calcium more frequently: preanalytical factors can be controlled and postanalytical data justify measurement
|
Glendenning, Paul |
|
2013 |
50 |
3 |
p. 191-193 |
article |
16 |
Molecular Genetics and Personalized Medicine
|
Newman, William G |
|
2013 |
50 |
3 |
p. 281-281 |
article |
17 |
Munchausen syndrome and factitious disorder: the role of the laboratory in its detection and diagnosis
|
Kinns, H |
|
2013 |
50 |
3 |
p. 194-203 |
article |
18 |
Osteoporosis: Pathophysiology and Clinical Management (2nd edn)
|
Moniz, Caje |
|
2013 |
50 |
3 |
p. 282-282 |
article |
19 |
Potential problems with using deuterated internal standards for liquid chromatography-tandem mass spectrometry
|
Davison, AS |
|
2013 |
50 |
3 |
p. 274-274 |
article |
20 |
Response to Basu et al
|
Pretorius, Carel J |
|
2013 |
50 |
3 |
p. 280-280 |
article |
21 |
Response to Pretorius: ‘Evaluation of the N Latex FLC free light chain assay on the Siemens BN analyser’
|
Basu, Supratik |
|
2013 |
50 |
3 |
p. 278-279 |
article |
22 |
Role of genetic testing in the management of patients with inherited porphyria and their families
|
Whatley, S D |
|
2013 |
50 |
3 |
p. 204-216 |
article |
23 |
The role of the laboratory in ensuring appropriate testing
|
Vasikaran, Samuel D |
|
2013 |
50 |
3 |
p. 283-284 |
article |
24 |
Use of glycated (glycosylated) haemoglobin in the diagnosis of diabetes mellitus in the United Kingdom. The implementation of World Health Organization guidance 2011
|
Ivanov, Petko |
|
2013 |
50 |
3 |
p. 287-287 |
article |